We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-5.07%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.24B
AUM Growth
-$48.8M
Cap. Flow
-$14.9M
Cap. Flow %
-0.46%
Top 10 Hldgs %
35.11%
Holding
101
New
30
Increased
21
Reduced
24
Closed
20

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$134M
2
HCA icon
HCA Healthcare
HCA
+$114M
3
AAPL icon
Apple
AAPL
+$108M
4
ELV icon
Elevance Health
ELV
+$69.3M
5
GILD icon
Gilead Sciences
GILD
+$69.3M

Top Sells

Rank Stock Value
1
AER icon
AerCap
AER
+$126M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$122M
3
SCHW
Charles Schwab
SCHW
+$91.5M
4
WBA
Walgreens Boots Alliance
WBA
+$85.3M
5
TXT icon
Textron
TXT
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 45.12%
2 Technology 13.88%
3 Financials 7.38%
4 Communication Services 6.63%
5 Consumer Discretionary 3.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYF icon
26
Synchrony
SYF
$23.7B
$50.6M 1.56%
1,766,019
-203,718
-10% -$5.66M
HAPN
27
Happen Inc
HAPN
$2.08B
$40.8M 1.26%
+983,517
New +$41.3M
META icon
28
Meta Platforms (Facebook)
META
$1.51T
$38.8M 1.2%
339,858
-184,889
-35% -$19.5M
NFLX icon
29
Netflix
NFLX
$292B
$37.8M 1.17%
3,698,730
-568,910
-13% -$5.58M
CLVS
30
DELISTED
Clovis Oncology, Inc.
CLVS
$36M 1.11%
1,874,384
-204,056
-10% -$4.32M
ARAY icon
31
Accuray
ARAY
$28.4M
$34M 1.05%
5,884,218
+760,070
+15% +$4.21M
AMAT icon
32
Applied Materials
AMAT
$426B
$33.3M 1.03%
+1,574,379
New +$28.7M
BKD icon
33
Brookdale Senior Living
BKD
$3.62B
$32M 0.99%
+2,012,993
New +$30.7M
TFCFA
34
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$31.6M 0.97%
+1,132,946
New +$30.3M
HLF icon
35
Herbalife
HLF
$1.23B
$30.1M 0.93%
+976,694
New +$25.2M
AERI
36
DELISTED
Aerie Pharmaceuticals
AERI
$29M 0.89%
2,381,135
+6,338
+0.3% +$100K
CHTR icon
37
Charter Communications
CHTR
$14.7B
$28.9M 0.89%
142,999
-2,326
-2% -$417K
XBI icon
38
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$28.1M 0.87%
+544,000
New +$28.3M
JAZZ icon
39
CALL
Jazz Pharmaceuticals
JAZZ
$15.9B
$27.7M 0.85%
+212,000
New +$26.4M
CRM icon
40
Salesforce
CRM
$134B
$26M 0.8%
+351,492
New +$24.2M
BPMC
41
DELISTED
Blueprint Medicines
BPMC
$25.6M 0.79%
1,420,511
+412,279
+41% +$7.15M
ZLTQ
42
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$24.4M 0.75%
898,129
+384,245
+75% +$9.06M
HYG icon
43
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$23.5M 0.72%
+287,300
New +$22.8M
BDX icon
44
Becton Dickinson
BDX
$43.1B
$22.2M 0.68%
+149,845
New +$21.3M
TCOM icon
45
Trip.com Group
TCOM
$27.5B
$21.6M 0.67%
+487,352
New +$20.4M
IBB icon
46
iShares Biotechnology ETF
IBB
$9.31B
$21M 0.65%
+241,539
New +$21.6M
EEM icon
47
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.5B
$19.9M 0.61%
+580,100
New +$18M
INVA icon
48
Innoviva
INVA
$1.58B
$18.7M 0.58%
1,486,214
-825,467
-36% -$9.06M
HOLX
49
DELISTED
Hologic
HOLX
$15.7M 0.48%
454,488
-962,240
-68% -$33.6M
CLVS
50
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$15.4M 0.48%
804,100
+479,000
+147% +$10.1M
1
2
3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q1 2016 Portfolio in Review

As of Q1 2016, PFM Health Sciences held 101 positions worth $3.24B, down 1.5% from $3.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

PFM Health Sciences's Q1 2016 filing shows 30 new, 21 increased, 24 reduced and 20 closed positions. Its largest new stake was AbbVie: 2,396,328 shares worth $137M. The largest sale was AerCap, an estimated $126M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 48% a quarter earlier, followed by Technology and Financials.

  • PFM Health Sciences's largest Q1 2016 buy was AbbVie: 2,396,328 shares worth $137M.
  • PFM Health Sciences added most to HCA Healthcare in Q1 2016, an estimated $114M increase.
  • PFM Health Sciences's biggest Q1 2016 reduction was Walgreens Boots Alliance, cutting an estimated $85.3M.
  • PFM Health Sciences fully exited AerCap in Q1 2016, selling an estimated $126M.
  • PFM Health Sciences's ten largest holdings make up 35% of its $3.24B portfolio in Q1 2016.
  • PFM Health Sciences opened 30 new positions and closed 20 in Q1 2016.
  • PFM Health Sciences's portfolio value fell 1.5% quarter-over-quarter to $3.24B.

Based on PFM Health Sciences's 13F filing for Q1 2016, filed 16 May 2016.